OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
55 hedge funds and large institutions have $24.2M invested in Orexigen Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 23 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
61% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 28
68% less call options, than puts
Call options by funds: $229K | Put options by funds: $706K
Holders
55
Holding in Top 10
2
Calls
$229K
Puts
$706K
Top Buyers
| 1 | +$1.11M | |
| 2 | +$877K | |
| 3 | +$696K | |
| 4 |
Morgan Stanley
New York
|
+$175K |
| 5 |
PP
PDT Partners
New York
|
+$99K |
Top Sellers
| 1 | -$4.26M | |
| 2 | -$349K | |
| 3 | -$294K | |
| 4 |
Renaissance Technologies
New York
|
-$236K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$202K |